Revolutionizing the Market Insight Report offerings valuable across the product lifecycle
Offer best-in-industry knowledge solutions & insights to transform the healthcare world
Enable clients to unlock the value potential for their assets
Cutting edge solution, robust analytics, and valuable insights empower evidence-based decision-making
Our Pillars
What’s new
Reports and Insights
Market Outlook and Forecast
Thelansis’s “Relapsed or Refractory Acute Lymphoblastic Leukemia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Relapsed or Refractory Acute Lymphoblastic Leukemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Market Outlook and Forecast
Thelansis’s “Non-Invasive Fungal Rhinosinusitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Non-Invasive Fungal Rhinosinusitis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Market Outlook and Forecast
Thelansis’s “Oculopharyngeal Muscular Dystrophy (OPMD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Oculopharyngeal Muscular Dystrophy treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Market Outlook and Forecast
Thelansis’s “Thymidine Kinase 2 Deficiency (TK2d) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Thymidine Kinase 2 Deficiency treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Market Access and Reimbursement Insights
Thelansis’s “Follicular Lymphoma (FL) Market Access and Reimbursement Insights Report – 2025″ provides comprehensive payer insights on the current and evolving market access and reimbursement environments for branded and emerging drugs in the indication. Our team understands the criticality of payer research and insights generation, as well as their importance during drug development, pre-market launch strategy, and post-marketing activities.
Epidemiology Insights and Forecast
Thelansis’s “Follicular Lymphoma (FL) Epidemiology Insights and Forecast Report – 2020 To 2040″ provides an analysis of disease burden, characterized by disease definition, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies.
Clients form the core of our values, and we strive to maintain the reputation of a ‘Valued Knowledge Partner’

Primary Market Research (PMR)
Our in-house web-based survey tools for KOLs help our client gather real-time data, market trends, and critical strategic insights. Global KOL Panel Management System comprises directories of Trial Investigators, Researchers, Healthcare Practitioners (HCPs), Payers, Regulatory bodies, and Conference Speakers. The tools provide flexibility to interact with interviewers anytime.

Therapy Area Expertise
Our teams comprise experienced market researchers, epidemiologists, market forecasters, PhDs, doctors, nurse practitioners, pharmacists, business consultants, and technology consultants with AI/ML expertise. Given the combination of therapy area and industry expertise for our team members, with the cumulative experience of 1,000+ years, we strive to deliver the best results for each project.

Market Forecasting
User-friendly forecast models and tools are built based on bottom-up and top-down methodologies, and they evaluate market trends, analogs, and various macro and micro indicators that possibly impact the current and future market.

24×7 Online Support
Integration of Thelansis Global support team across continents offers support round the clock for all locations, no matter which region or country you are in.

Interactive Platform
Our multiple report offerings are available on an interactive web-based platform to quickly filter and analyze relevant data.

Customized Offerings
We often customize our syndicated report content to suit client needs.
Years Experience
Experts
Physicians in Panel
Payers in Panel
Global Delivery Centers
Delivered Market Outlook Reports in 2024
Client Reviews
Hear from happy customers about their experience working with us.
“Support on current drug utilizations and benchmarking of emerging therapy, greatly helped us in narrowing down on patient share estimations for internal calculations ״
Santen PharmaDirector
“Patient share for approved therapies are estimated perfectly. Indeed it's great pieces of work. I liked the way segmentation was shown and patient flow was discussed״
Vicore PharmaDirector
“Happy to read the market insight report, really informative and applied to build marketing strategy״
NewronDirector
“This is the first time I worked with Thelansis, I could say the team is truly professional, Cheers guys ״
SanquinDirector
“ We want to congratulate team Thelansis for their continuous support during this tough time ״
WEX TherapeuticsDirector
"We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "
Reata PharmaceuticalsVice President
" We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "
Stemline TherapeuticsVice President- Marketing
"Some great piece of patient based forecast model; and market assumptions. Tying up beautifully with the payer's insights "
CamurusDirector
"Liked the way the outcome was structured. Regulatory assessment was spot-on. Country-wise regulatory scenarios were gold to us at this point"
Asarina PharmaDirector
"Satisfied with the companies core competency around Clinical Trial Outcome analysi"
Acadia PharmaceuticalsDirector
Need customize support?
Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.











